Curriculum Vitae: Sean F. Regan
March 2005 Page 7
CURRICULUM VITAE
Sean F. Regan, RN, BSN, MSN, CS-FNP, MBA
Norfolk, Virginia
757.478.2578
EDUCATION:
Degree: Old Dominion University
Master of Business Administration
Norfolk, Virginia, 2008
Degree: Hampton University
Master of Science in Nursing
Hampton, Virginia, 1998
Degree: Old Dominion University
Bachelor of Science in Nursing
Norfolk, Virginia, 1995
Certificates: ANCC Family Nurse Practitioner Certification
Advanced Cardiopulmonary Life Support
Basic Cardiopulmonary Life Support
PROFESSIONAL EXPERIENCE:
Medi-Hospice
February 2011 – Present
Nurse Practitioner
LongTerm Care of Virginia, PC.
February 2002 – Present
Nurse Practitioner/Principal Owner/Executive Officer
Eastern Virginia Medical School, The Glennan Center for Geriatrics and Gerontology.
March 1999 - February 2002
Nurse Practitioner/Associate Director of Clinical Services
National Nurse Service, Inc
1999-2000 (PRN Basis)
1998-1999 (Full Time)
RN (ICU/ICCU/SICU/MICU/ED)
Mary Immaculate Hospital - Newport News, Virginia
1996-1998
ICU/ICCU-Staff RN/Charge Nurse.
Cumberland Hospital - New Kent, Virginia
1995-1996
RN - Acute Care Unit
LICENSURE:
0017136796- Licensed Nurse Practitioner (Virginia Board of Nursing)
147751- Licensed Registered Nurse (Virginia Board of Nursing)
500000751 – Medicare Provider Number
ASSOCIATIONS:
Forest Pharmaceuticals Speakers Bureau 2004
NCGNP Practice Committee Member 2002
American Academy of Nurse Practitioners
American Geriatrics Society
Virginia Council of Nurse Practitioners
Gerontological Nurse Practitioner Association
American Association of Critical Care Nurses
CLINICAL INVESTIGATIONS:
A Multicenter, Double-Blind, Parallel Group Study Comparing the Incidence of Clinically Significant Upper Gastrointestinal Adverse Events Associated with SC-58635 400 MG BID to that of Diclofenac 75 MG BID in Patients with Osteoarthritis or Rheumatoid Arthritis
Protocol: N49-98-12-102
Role: Sub-Investigator
Sponsor: Searle Research and Development, 1998
Evaluation of the Antihypertensive Efficacy of Candesartan Cilexetil in Comparison to Losartan: A Multicenter, Double-blind, Randomized, Parallel-group, Forced-titration Study.
Role: Sub-Investigator
Protocol: 231 Sponsor: AstraZeneca, 1999
Predicting Outcomes in Older Adults Presenting to the Emergency Department With a Change in Health Status.
Role: Sub-Investigator
Sponsor: Commonwealth Health Research Board, 1999
A Three-Year, Multicenter, Double-Blind Clinical Trial to Assess the Safety and Efficacy of Hormone Replacement Therapy to Prevent Alzheimer’s Disease in Women With a Family History of Alzheimer’s Disease.
Role: Sub-Investigator
Sponsor: National Institute on Aging, 1999
A Double-Blind, Placebo-Controlled, Randomized Study Comparing The Effects Of
CVT- E002 (American Ginseng Extract) And Placebo In Naturally-Occuring
Respiratory.
Role: Sub-Investigator
Sponsor: CV Technologies, Inc., 1999
A Double-Blind, Stratified, Randomized, Placebo Controlled Study of Ro-0796 (also known as GS4104) in the treatment of influenza infection in elderly adults.
Role: Sub-Investigator
Sponsor: F Hoffmann-La Roche Ltd, 1999
A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study to Investigate the Efficacy and Safety of Inhaled Zanamavir 10mg Administered Twice Daily for five Days in the Treatment of symptomatic influenza A and B viral infections in subjects >65 years.
Role: Sub-Investigator
Sponsor: Glaxo Wellcome, 1999
Natural Course of Respiratory Synctial Virus (RSV) Titers in Pediatric and Adult Populations During the 1999-2000 Season.
Role: Sub-Investigator
Sponsor: Genetic Institute, 1999
A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study to Investigate the Efficacy and Safety of Inhaled Zanamavir 10mg Administered once a day Compared to the Standard of Care in Controlling Nursing Home Influenza Outbreaks.
Role: Sub-Investigator
Sponsor: Glaxo Wellcome, 1999
Study on Cognition and Prognosis (SCOPE).
Role: Sub-Investigator
Sponsor: AstraZeneca, 2000
Safety and Immunogenicity of Influenza Virus and Vaccine USP Trivalent Types A and B (Zonal Purified Subvirion) Fluzone 2000/2001 Formula.
Role: Sub-Investigator
Sponsor: Aventis Pasteur, 2000
Safety and Immunogenicity of Tetanus and Diptheria Toxoids Component Pertusis (TdcP) Vaccine Compared To Tetanus And Diphtheria Toxoids Absorbed (Td) In Adolescents And Adults 11-64 Years Of Age.
Role: Sub-Investigator
Sponsor: Aventis Pasteur Limited, 2001
Safety and Dose Escalation of a Pneumococcal Surface Protein A (PspA) Vaccine for Streptococcus pneumoniae in Adults.
Role: Sub-Investigator
Sponsor: Aventis Pasteur Limited, 2001
Comparison of Immune Responses in the Instituionalized Elderly to Influenza Vaccine Administered Intradermally (0.1 ml) with the Biojector 2000 Needle-Free Injection Management System or Intramuscularly (0.5 ml) with Needle and Syringe.
Sponsor: Bioject, Inc., 2001/2002
A Randomized, Double-Blind, Placebo Controlled Evaluation of the Safety and Efficacy of Memantine in Non-Institutionalized Agitated Patients with Moderate to Severe Alzheimer’s Disease.
Role: Sub-Investigator
Sponsor: Forest Laboratories, Inc. 2005
MEM-MD-51
Role: Sub-investigator
Sponsor: Forest Laboratories, Inc. 2005
LECTURES:
June 3, 2003
Topic: Behavioral disturbances related to dementia
Audience: Virginia Occupational Therapists Association
June 4, 2003
Topic: Understanding and managing dementia
Audience: The Chesapeake
Sponsor: Long Term Care of Virginia
Eastern Virginia Medical School
Geriatric Clerkship Preceptor
April 2001 – 2002
Mentoring second and fourth year medical students during geriatric rotations.
Hampton University
Summer 2002
Adjunct Faculty
Legal Aspects of Advance Practice 6/19/02
Geriatric Physical Examination 6/26/02
June 19, 2001
Topic: Nurse Practitioners and Geriatric Care
Audience: EVMS Grand Rounds
October 2001
Topic: The Future of Geriatric Medicine
Audience: National Alliance of Allied Healthcare Professionals
October 2001
Topic: The Biology of Aging
Audience: Catholic Charities, Staff Inservice
November 2001
Topic: Healthcare trends related to aging
Audience: Grand Rounds, Richmond VAMC
February 11, 2000
Topic – Memory Loss and Aging
NPR Radio Rounds
February 2000
Topic – How to manage the cognitively impaired client
Facility Inservice: Chesapeake Place Assisted Living/Alzheimer Care Community
July 28, 2000
Topic: Heat-related illness
Audience: Warwick Forest Assisted Living
September 28, 2000
Topic: Influenza
Audience: Warwick Forest Assisted Living
November 10, 2000
Topic: Communicating with the Elderly
Audience: EMS Symposium
September 2, 1999
Topic – Incontinence & Aging
Parks and Recreation Mature Adult Program - Newport News, VA
November 1999
Topic – The Role of the Nurse Practitioner
Geriatric Clerkship, EVMS
November 1999
Topic - Influenza
Community Lecture
Volunteer:
Portsmouth Medical Center
Board of Directors
2007 -2008
East Ocean View Civic League
Director At-Large
2007 – Present
East Ocean View Action League
Vice-President
2008 - Present
PUBLICATIONS:
Regan, S. & Fowler, C. (2000). Influenza: Past, present, & future. Journal of Gerontological Nursing.
Regan, S., Fowler, C., & Gravenstein, S. Antiviral therapy in influenza. Geriatric Times.
Regan, S., Fowler, C., & Gravenstein, S. Management of influenza in assisted-living and long term care facilities. Poster Presentation, American Geriatrics Society, 2001 Annual Conference.
Regan, S. Influenza: Management and treatment options. Abstract, Gerontological Nurse Practitioner Association, 2001 Annual Conference.